Cargando…

Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India

Aim of this study was to estimate the prevalence of cerebrospinal fluid (CSF)/Plasma HIV-1 RNA discordance in virologically suppressed individuals presenting with incident neurologic symptoms. In this retrospective cohort study conducted between March 1, 2009, and March 1, 2017, HIV-1 infected adult...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dravid, Ameet N., Natrajan, Kartik, Kulkarni, Milind M., Saraf, Chinmay K., Mahajan, Uma S., Kore, Sachin D., Rathod, Niranjan M., Mahajan, Umakant S., Wadia, Rustom S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	4850
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841989/ https://www.ncbi.nlm.nih.gov/pubmed/29465595 http://dx.doi.org/10.1097/MD.0000000000009969

Ejemplares similares

Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India
por: Dravid, Ameet N., et al.
Publicado: (2020)

Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India
por: Dravid, Ameet, et al.
Publicado: (2019)

Efficacy and safety of 400 mg efavirenz versus standard 600 mg dose when taken with tenofovir and lamivudine combination in Indian adult patients with HIV-1 infection: An open-label, interventional, randomized, non-inferiority trial
por: Dravid, Ameet, et al.
Publicado: (2022)

Safety of low dose efavirenz regimen in Indian adults with HIV-1 infection: Insights from a phase 4 interventional randomised trial
por: Dravid, Ameet N., et al.
Publicado: (2023)

Factors associated with immunological and virological discordant responses to highly active antiretroviral therapy among adult HIV positive individuals in Ethiopia: A cross-sectional study
por: Manaye, Gizachew Ayele, et al.
Publicado: (2021)

Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India
por: Dravid, A, et al.
Publicado: (2020)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India
por: Karade, Santosh K., et al.
Publicado: (2016)

Elevated CD8 T-cell counts and virological failure in HIV-infected patients after combination antiretroviral therapy
por: Ku, Nam Su, et al.
Publicado: (2016)

Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV
por: Sangaré, Mohamed N’dongo, et al.
Publicado: (2020)

Should viral load thresholds be lowered?: Revisiting the WHO definition for virologic failure in patients on antiretroviral therapy in resource-limited settings
por: Labhardt, Niklaus D., et al.
Publicado: (2016)

Discordant retention of HIV-infected mothers and children: Evidence for a family-based approach from Southern Mozambique
por: Nhampossa, Tacilta, et al.
Publicado: (2020)

HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017
por: Yuan, Dan, et al.
Publicado: (2019)

Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure
por: Avendaño-Ortiz, José, et al.
Publicado: (2020)

Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study
por: Llibre, Josep M., et al.
Publicado: (2016)

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals
por: Cain, Lauren E., et al.
Publicado: (2016)

Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics
por: Fokam, Joseph, et al.
Publicado: (2023)

Nevirapine plasma concentration is associated with virologic failure and the emergence of drug-resistant mutations among HIV patients in Kenya: A cross sectional study
por: Omondi, Evans Okumu, et al.
Publicado: (2022)

Diagnostic value of EBV-DNA in CSF for PCNSL in AIDS patients with focal brain lesions: A meta-analysis of diagnostic test
por: Ding, Xinghuan, et al.
Publicado: (2022)

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study
por: Mossoro-Kpinde, Christian Diamant, et al.
Publicado: (2017)

Prevalence of low bone mineral density among HIV patients on long-term suppressive antiretroviral therapy in resource limited setting of western India
por: Dravid, Ameet, et al.
Publicado: (2014)

Strongyloidosis Hyperinfection Syndrome in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome
por: Natrajan, Kartik, et al.
Publicado: (2018)

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2015)

Antiretroviral treatment failure and associated factors among HIV patients on the first-line antiretroviral therapy at Mizan-Tepi University teaching hospital, Southwest Ethiopia: A cross-sectional study
por: Siraj, Jafer, et al.
Publicado: (2021)

Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals
por: Shilaih, Mohaned, et al.
Publicado: (2017)

Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries
por: Tierrablanca, Luis Enrique, et al.
Publicado: (2018)

The investigation of CD4(+)T-cell functions in primary HIV infection with antiretroviral therapy
por: Sun, Yu, et al.
Publicado: (2017)

Sarcopenia among people living with HIV and the effect of antiretroviral therapy on body composition
por: Konishi, Keiji, et al.
Publicado: (2022)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

Genotyping and antiretroviral drug resistance of human immunodeficiency Virus-1 in Jazan, Saudi Arabia
por: Zaki, Eitezaz A., et al.
Publicado: (2020)

Immune recovery of middle-aged HIV patients following antiretroviral therapy: An observational cohort study
por: Wong, Ngai Sze, et al.
Publicado: (2017)

Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice
por: Drozd, Daniel R., et al.
Publicado: (2017)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia
por: Jordan, Michael R., et al.
Publicado: (2020)

Trends & predictors of non-AIDS comorbidities among people living with HIV and receiving antiretroviral therapy in Lebanon
por: Abou Hassan, Farouk F., et al.
Publicado: (2022)

Community-based point-of-care testing to identify new HIV infections: A cross-sectional study from Pune, India
por: Mamulwar, Megha, et al.
Publicado: (2021)

Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study
por: Masiá, Mar, et al.
Publicado: (2016)

High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy
por: Gangcuangco, Louie Mar A., et al.
Publicado: (2016)

Natural conception in HIV-serodiscordant couples with the infected partner in suppressive antiretroviral therapy: A prospective cohort study
por: Del Romero, Jorge, et al.
Publicado: (2016)

Superior Glucose Tolerance and Metabolomic Profiles, Independent of Adiposity, in HIV-Infected Women Compared With Men on Antiretroviral Therapy
por: Koethe, John R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_boclnkt2b3d59ebgvpgh0ms6pn